Sign in
4

Changes in Ownership

PharmaCyte Biotech, Inc. Filed Acc 0001683168-22-008706

Options or other derivatives

  • Director acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Allen Daniel Director 2022-12-28 Grant or award · Stock Option (Right to Buy) +125,000 125,000 D
Loading xslF345X03/ownership.xml…